416 related articles for article (PubMed ID: 27798166)
1. mTOR Signaling Regulates Protective Activity of Transferred CD4+Foxp3+ T Cells in Repair of Acute Kidney Injury.
Chen G; Dong Z; Liu H; Liu Y; Duan S; Liu Y; Liu F; Chen H
J Immunol; 2016 Nov; 197(10):3917-3926. PubMed ID: 27798166
[TBL] [Abstract][Full Text] [Related]
2. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
[TBL] [Abstract][Full Text] [Related]
3. mTOR regulates neuroprotective effect of immunized CD4+Foxp3+ T cells in optic nerve ischemia.
Chen G; Tang L; Wei W; Li Z; Li Y; Duan X; Chen H
Sci Rep; 2016 Nov; 6():37805. PubMed ID: 27886260
[TBL] [Abstract][Full Text] [Related]
4. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
5. Double-negative T cells have a reparative role after experimental severe ischemic acute kidney injury.
Lee K; Gharaie S; Kurzhagen JT; Newman-Rivera AM; Arend LJ; Noel S; Rabb H
Am J Physiol Renal Physiol; 2024 Jun; 326(6):F942-F956. PubMed ID: 38634135
[TBL] [Abstract][Full Text] [Related]
6. Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells.
Bergström M; Müller M; Karlsson M; Scholz H; Vethe NT; Korsgren O
Cell Transplant; 2019 Dec; 28(12):1603-1613. PubMed ID: 31512504
[TBL] [Abstract][Full Text] [Related]
7. Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury.
Gandolfo MT; Jang HR; Bagnasco SM; Ko GJ; Agreda P; Satpute SR; Crow MT; King LS; Rabb H
Kidney Int; 2009 Oct; 76(7):717-29. PubMed ID: 19625990
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.
Sugiyama H; Maeda Y; Nishimori H; Yamasuji Y; Matsuoka K; Fujii N; Kondo E; Shinagawa K; Tanaka T; Takeuchi K; Teshima T; Tanimoto M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):183-91. PubMed ID: 24333142
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis repressor with caspase recruitment domain deficiency accelerates ischemia/reperfusion (I/R)-induced acute kidney injury by suppressing inflammation and apoptosis: The role of AKT/mTOR signaling.
Yingjie K; Haihong Y; Lingwei C; Sen Z; Yuanting D; Shasha C; Liutong P; Ying W; Min Z
Biomed Pharmacother; 2019 Apr; 112():108681. PubMed ID: 30970510
[TBL] [Abstract][Full Text] [Related]
10. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.
Koo TY; Lee JG; Yan JJ; Jang JY; Ju KD; Han M; Oh KH; Ahn C; Yang J
Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117
[TBL] [Abstract][Full Text] [Related]
11. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
[TBL] [Abstract][Full Text] [Related]
12. Foxp3+ T cells inhibit antitumor immune memory modulated by mTOR inhibition.
Wang Y; Sparwasser T; Figlin R; Kim HL
Cancer Res; 2014 Apr; 74(8):2217-28. PubMed ID: 24574514
[TBL] [Abstract][Full Text] [Related]
13. IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.
Stremska ME; Jose S; Sabapathy V; Huang L; Bajwa A; Kinsey GR; Sharma PR; Mohammad S; Rosin DL; Okusa MD; Sharma R
J Am Soc Nephrol; 2017 Sep; 28(9):2681-2693. PubMed ID: 28539382
[TBL] [Abstract][Full Text] [Related]
14. The heat-shock protein-70-induced renoprotective effect is partially mediated by CD4+ CD25+ Foxp3 + regulatory T cells in ischemia/reperfusion-induced acute kidney injury.
Kim MG; Jung Cho E; Won Lee J; Sook Ko Y; Young Lee H; Jo SK; Cho WY; Kim HK
Kidney Int; 2014 Jan; 85(1):62-71. PubMed ID: 23884338
[TBL] [Abstract][Full Text] [Related]
15. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells.
Zeiser R; Leveson-Gower DB; Zambricki EA; Kambham N; Beilhack A; Loh J; Hou JZ; Negrin RS
Blood; 2008 Jan; 111(1):453-62. PubMed ID: 17967941
[TBL] [Abstract][Full Text] [Related]
16. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling.
Liang CL; Lu W; Zhou JY; Chen Y; Zhang Q; Liu H; Qiu F; Dai Z
Cell Physiol Biochem; 2018; 50(4):1560-1573. PubMed ID: 30359968
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells contribute to the protective effect of ischemic preconditioning in the kidney.
Kinsey GR; Huang L; Vergis AL; Li L; Okusa MD
Kidney Int; 2010 May; 77(9):771-80. PubMed ID: 20164824
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.
Huijts CM; Santegoets SJ; Quiles Del Rey M; de Haas RR; Verheul HM; de Gruijl TD; van der Vliet HJ
Clin Immunol; 2016 Jul; 168():47-54. PubMed ID: 27189717
[TBL] [Abstract][Full Text] [Related]
19. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-15b/16 Enhances the Induction of Regulatory T Cells by Regulating the Expression of Rictor and mTOR.
Singh Y; Garden OA; Lang F; Cobb BS
J Immunol; 2015 Dec; 195(12):5667-77. PubMed ID: 26538392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
